0

Studies of Monoclonal and Polyclonal Anti-Digoxin Antibodies for Serum Digoxin Radioimmunoassay

B E Bång, M Hurme, K Juntunen, O Mäkelä

Scand J Clin Lab Invest. 1981 Feb;41(1):75-8.

PMID: 7256195

Abstract:

We compared the advantages of monoclonal antibodies (produced by plasma cell-myeloma cell hybrid lines) and those of conventional antibodies in the radioimmunoassay of digoxin. It was found that antibodies produced by some hybrid cell lines (hybridomas) were highly specific for the digoxin structure; this way the cross-reactions to related structures (e.g. spironolactone) could be avoided. When the hybridoma lines were grown in ascites, the resulting fluid could have as high or higher titre than the serum of a hyperimmunized rabbit. The high titre, the specificity and the permanent growth of the hybridoma lines make them an optimal source of the specific antibody in clinical radioimmunoassays for the measurement of drug or hormone levels.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR4247825 Anti-Digoxin antibody produced in rabbit Anti-Digoxin antibody produced in rabbit Price
IAR4247826 Monoclonal Anti-Digoxin antibody produced in mouse Monoclonal Anti-Digoxin antibody produced in mouse Price
qrcode